SI-BONE A.I CyberSecurity Scoring
31/03/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for SI-BONE in 2026.
No incidents recorded for SI-BONE in 2026.
No incidents recorded for SI-BONE in 2026.
Medical Device
A Global Total Solutions Provider Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. Our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products. Dentsply Sirona is one global team that brings out the best in our people, lives and breathes high performance and personal accountability, acts with uncompromising integrity, improves the practice of dentistry with an unrelenting commitment to our customers and demonstrates a passion for innovation that shapes the dental industry. As The Dental Solutions Company™ Dentsply Sirona’s comprehensive solutions offering includes leading product brands across consumables, equipment, technology and specialty products. With the broadest clinical education platform and an unparalleled commitment to R&D in dentistry, our mission and vision guide us to continuously aim higher, support our customers and advance patient care around the world. Dentsply Sirona’s Global Headquarters is located in Charlotte, North Carolina. Our shares are listed in the United States on NASDAQ under the symbol XRAY. We care about your privacy - you can view our Privacy Policy here: http://www.dentsplysirona.com/privacy.
Latest updates, reports, and threat intel affecting the global network.
Spartan Medical® and SI-BONE® announce new partnership to expand access to advanced ultra–minimally invasive treatment options for...
Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for...
Achieved record 2025 revenue of $201 million, driven by a 22% increase in U.S. physician adoption and expanded utilization across the...
Morgan Stanley analyst Patrick Wood maintained a Buy rating on SI-Bone today and set a price target of $23.00. Patrick Wood has given his...
Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio.
Truist raised the firm's price target on SI-Bone (SIBN) to $24 from $23 and keeps a Buy rating on the shares after its Q4 earnings beat.
SI-BONE Q4 Loss Narrows, Revenue Rises. Published on 02/23/2026 at 05:18 pm EST. MT Newswires. mtnewswires logo. © MT Newswires - 2026.
FDA Breakthrough pelvic implant iFuse TORQ TNT enters Smith+Nephew's trauma portfolio via SI-BONE deal, with NTAP up to $4136 per procedure.
Si-Bone (SIBN) delivered earnings and revenue surprises of +69.23% and +0.09%, respectively, for the quarter ended December 2025.
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.
IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.
IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.
IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.